Nuclear MD

https://www.auntminnie.com/clinical-news/molecular-imaging/article/15833655/pet-outperforms-ct-in-ovarian-American Cancer Society

PET outperforms CT in ovarian cancer Peritoneal carcinomatosis in ovarian cancer is cancer that has spread from the ovaries to the peritoneum.

😂😂

Case Challenge: # 78

Test your skills by providing answers in comments. Come back to check the answer key in 24 -48h.

Get all the cases at: https://nuclearmd.com/courses

https://youtu.be/5NJsZY86EWk

Sarcoma; Meningiomas; Hydronephrosis www.nuclearmd.com

Hepatic Hemangioma on Tc-99m Labeled RBC Scan ☢️
A classic case demonstrating a hepatic hemangioma on Tc-99m labeled red blood cell scintigraphy—with characteristic delayed blood-pool filling and increased tracer accumulation within the lesion.

The “Nubbin Sign” on Hepatobiliary Scintigraphy ☢️
A fascinating example of the Nubbin sign on a HIDA scan—radiotracer activity extending into the gallbladder neck/cystic duct region, creating a characteristic appearance that can be associated with acute cholecystitis.

📚☢️ Nuclear Medicine Learning—Anywhere, Anytime

Happy to highlight my Apple Books nuclear medicine e-books, created to make practical nuclear medicine learning accessible to residents, fellows, technologists, and anyone interested in molecular imaging.

📘 Nuclear Medicine Handbook — a practical resource covering the fundamentals and everyday clinical applications of nuclear medicine.

📕 Nuclear Medicine Cases and MCQs — case-based learning and multiple-choice questions designed to reinforce key concepts and prepare for real-world interpretation.

From PET/CT and SPECT to theranostics and radiopharmaceutical therapy, these books are designed with one goal: make nuclear medicine easier to learn and apply.

📱 Available on Apple Books.

☢️ Learn. Interpret. Treat.

The Yin and Yang of Nuclear Medicine ☯️
One finds the target. 🎯The other treats it. ☢️

Gallium-68 allows us to see where disease is by targeting specific molecular receptors on PET imaging.Lutetium-177 uses the same molecular targeting concept to deliver radiation directly to those cancer cells.

Together, they represent the essence of THERANOSTICS — diagnosis and therapy as two complementary halves of precision medicine.